NCT03337386

Brief Summary

Traditional methods for intravascular volume status assessment include physical examination, raised leg test, central venous pressure (CVP) and pulmonary artery catheters occlusion pressure (PAWP). Central venous pressure and pulmonary artery occlusion pressure are invasive and associated with significant complications. More recently, a number of less invasive techniques have been introduced, but they lack standardization and reliability. Ultrasonically, inferior vena cava collapsibility can detect hypovolemia non-invasively.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
64

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2017

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 3, 2017

Completed
6 days until next milestone

First Posted

Study publicly available on registry

November 9, 2017

Completed
3 days until next milestone

Study Start

First participant enrolled

November 12, 2017

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 10, 2018

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

May 20, 2018

Completed
Last Updated

September 18, 2020

Status Verified

September 1, 2020

Enrollment Period

5 months

First QC Date

November 3, 2017

Last Update Submit

September 16, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • inferior vena cava collapsibility index changes

    ultrasound M mode maximum minus minimum over maximum then multiply by 100

    intraoperative changes:1st basal before induction of anesthesia, 2nd before start of surgery, 3rd after10 ml/kg ringers preload, 4th 5 minutes before extubation.

Secondary Outcomes (7)

  • subclavian vein collapsibility index changes

    intraoperative changes:1st basal before induction of anesthesia, 2nd before start of surgery, 3rd after 10 ml/kg ringers preload, 4th 5 minutes before extubation.

  • central venous pressure changes

    intraoperative changes:1st basal before induction of anesthesia, 2nd before start of surgery, 3rd after 10 ml/kg ringers preload, 4th 5 minutes before extubation.

  • heart rate changes

    intraoperative changes:1st basal before induction of anesthesia, 2nd before start of surgery, 3rd after 10 ml/kg ringers preload, 4th 5 minutes before extubation.

  • mean blood pressure changes

    intraoperative changes:1st basal before induction of anesthesia, 2nd before start of surgery, 3rd after 10 ml/kg ringers preload, 4th 5 minutes before extubation.

  • fluid administration

    Intraoperative

  • +2 more secondary outcomes

Study Arms (3)

Inferior Vena Cava Collapsibility

EXPERIMENTAL

inferior vena cava diameters is obtained in the supine position with a convex probe .The probe is placed in the subxiphoid region or the right anterior midaxillary plane.The sagittal section of IVC is imaged. M-mode probe is used to identify the measurement of minimum and maximum venous dimensions over the respiratory cycle using the 3.5-5 MHz phased array probe. To standardize the measurements, measuring of the IVC diameter is performed at 2 cm caudal of the junction point of the right atrium and IVC. The difference between the maximum (D max) and minimum (D min)diameters of the target vein is normalized according to the standard formula to yield the collapsibility index (CI).

Diagnostic Test: inferior vena cava collapsibility

Subclavian Vein Collapsibility

EXPERIMENTAL

Right SCV diameters is checked in the supine position using a high frequency linear array probe (6-13 MHz) and M-mode. To standardize the measurements, the probe is placed beneath the proximal part of the middle part of the clavicle perpendicular to long-axis of the SCV to obtain the best cross-sectional view of the vien. After the target vein is localized , the dynamic diameter change is recorded using M-mode to identify and measure the minimum and maximum venous diameters.To calculate SCV collapsibility index, the standard formula is used.

Diagnostic Test: subclavian vein collapsibility

central venous pressure

ACTIVE COMPARATOR

ultrasound guided 7.5-F central venous catheter is introduced via right internal jugular vein under local analgesia with 2% lidocaine for measuring the CVP.

Diagnostic Test: central venous pressure

Interventions

inferior vena cava diameters is obtained in the supine position with a convex probe .The probe is placed in the subxiphoid region or the right anterior midaxillary plane.The sagittal section of IVC is imaged. M-mode probe is used to identify the measurement of minimum and maximum venous dimensions over the respiratory cycle using the 3.5-5 MHz phased array probe. To standardize the measurements, measuring of the IVC diameter is performed at 2 cm caudal of the junction point of the right atrium and IVC. The difference between the maximum (D max) and minimum (D min)diameters of the target vein is normalized according to the standard formula to yield the collapsibility index (CI).

Inferior Vena Cava Collapsibility

Right SCV diameters is checked in the supine position using a high frequency linear array probe (6-13 MHz) and M-mode. To standardize the measurements, the probe is placed beneath the proximal part of the middle part of the clavicle perpendicular to long-axis of the SCV to obtain the best cross-sectional view of the vien. After the target vein is localized , the dynamic diameter change is recorded using M-mode to identify and measure the minimum and maximum venous diameters.To calculate SCV collapsibility index, the standard formula is used.

Subclavian Vein Collapsibility

ultrasound guided 7.5-F central venous catheter is introduced via right internal jugular vein under local analgesia with 2% lidocaine for measuring the CVP.

central venous pressure

Eligibility Criteria

Age20 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • \. American society of anaesthesiologists physical status grade I and grade II .
  • \. Elective laparotomy. 3. Supine position

You may not qualify if:

  • Patient refusal .
  • Portal hypertension .
  • Severe peripheral vascular diseases.
  • Obstructive lung diseases .
  • Right sided heart failure , arrhythmia and valvular heart heart diseases .
  • Body mass index \>35 kg/m2

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Oncolgy Center, Mansoura University,

Al Mansurah, DK, Egypt

Location

MeSH Terms

Interventions

Central Venous Pressure

Intervention Hierarchy (Ancestors)

Venous PressureBlood PressureHemodynamicsCardiovascular Physiological PhenomenaCirculatory and Respiratory Physiological Phenomena

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate professor of anesthesia and surgical intensive care

Study Record Dates

First Submitted

November 3, 2017

First Posted

November 9, 2017

Study Start

November 12, 2017

Primary Completion

April 10, 2018

Study Completion

May 20, 2018

Last Updated

September 18, 2020

Record last verified: 2020-09

Locations